ZA981609B - Method of treating a tumor - Google Patents

Method of treating a tumor

Info

Publication number
ZA981609B
ZA981609B ZA981609A ZA981609A ZA981609B ZA 981609 B ZA981609 B ZA 981609B ZA 981609 A ZA981609 A ZA 981609A ZA 981609 A ZA981609 A ZA 981609A ZA 981609 B ZA981609 B ZA 981609B
Authority
ZA
South Africa
Prior art keywords
mammal
administering
effective amount
tumor
treating
Prior art date
Application number
ZA981609A
Other languages
English (en)
Inventor
Daniel L Dexter
Paul E Juniewicz
James B Rake
Daniel D Van Hoff
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of ZA981609B publication Critical patent/ZA981609B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA981609A 1997-03-07 1998-02-26 Method of treating a tumor ZA981609B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81476997A 1997-03-07 1997-03-07

Publications (1)

Publication Number Publication Date
ZA981609B true ZA981609B (en) 1998-12-08

Family

ID=25215967

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981609A ZA981609B (en) 1997-03-07 1998-02-26 Method of treating a tumor

Country Status (15)

Country Link
US (2) US6063780A (fr)
EP (1) EP1014990B1 (fr)
JP (1) JP2001513110A (fr)
AT (1) ATE338553T1 (fr)
AU (1) AU6178198A (fr)
BR (1) BR9808221A (fr)
CA (1) CA2281807C (fr)
DE (1) DE69835824T2 (fr)
DK (1) DK1014990T3 (fr)
ES (1) ES2268764T3 (fr)
HR (1) HRP980095A2 (fr)
NO (1) NO324974B1 (fr)
PT (1) PT1014990E (fr)
WO (1) WO1998039009A1 (fr)
ZA (1) ZA981609B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281807C (fr) * 1997-03-07 2007-10-16 Sanofi Pharmaceuticals, Inc. Methode de traitement d'une tumeur
EP1121117B1 (fr) * 1998-10-14 2002-06-05 Debiopharm S.A. Conditionnement d'une preparation d'oxaliplatine
DE19925211B4 (de) * 1999-06-01 2006-01-12 PBS Pharmaceutical Bulk Substances SA Kit zur Herstellung einer Formulierung von Paclitaxel
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
CN1170533C (zh) * 1999-08-30 2004-10-13 德比奥法姆股份有限公司 用于肠胃外给药的药学上稳定的奥沙利铂制剂
EP1341555A2 (fr) 2000-12-12 2003-09-10 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
US20080107721A1 (en) * 2003-05-20 2008-05-08 Jonathan Lewis Combination Chemotherapy Comprising A Liposomal Platinum Complex
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US20060275331A1 (en) * 2004-08-31 2006-12-07 Borek Zaludek Pharmaceutical composition, method of manufacturing and therapeutic use thereof
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
JP2009510165A (ja) * 2005-10-03 2009-03-12 ジェネティックス ファーマシューティカルズ， インク． 低酸素細胞を選択的に枯渇させるための方法
US20070212360A1 (en) * 2006-01-17 2007-09-13 Denko Nicholas C Modulation of mitochondrial oxygen consumption for therapeutic purposes
US8026017B2 (en) 2007-03-16 2011-09-27 The United States Of America As Represented By The Secretary Of The Army High voltage methanol fuel cell assembly using proton exchange membranes and base/acid electrolytes
WO2009126705A2 (fr) 2008-04-10 2009-10-15 Virginia Commonwealth University Induction d'une hypoxie tumorale pour une thérapie du cancer
WO2014062856A1 (fr) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxie et hyaluronane et leurs marqueurs pour le diagnostic et la surveillance de maladies et de pathologies, et méthodes associées
EP4201403A1 (fr) * 2021-12-21 2023-06-28 Som Innovation Biotech, S.L. Composés tirapazamine et quazinone à utiliser dans le traitement des gangliosidoses gm2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
CA2281807C (fr) * 1997-03-07 2007-10-16 Sanofi Pharmaceuticals, Inc. Methode de traitement d'une tumeur

Also Published As

Publication number Publication date
EP1014990B1 (fr) 2006-09-06
EP1014990A1 (fr) 2000-07-05
CA2281807A1 (fr) 1998-09-11
BR9808221A (pt) 2000-05-16
WO1998039009A1 (fr) 1998-09-11
US6063780A (en) 2000-05-16
HRP980095A2 (en) 1998-12-31
PT1014990E (pt) 2006-11-30
ATE338553T1 (de) 2006-09-15
CA2281807C (fr) 2007-10-16
NO994330D0 (no) 1999-09-06
DE69835824D1 (de) 2006-10-19
NO324974B1 (no) 2008-01-14
EP1014990A4 (fr) 2004-03-24
JP2001513110A (ja) 2001-08-28
AU6178198A (en) 1998-09-22
ES2268764T3 (es) 2007-03-16
US6319923B1 (en) 2001-11-20
DE69835824T2 (de) 2007-03-29
NO994330L (no) 1999-10-25
DK1014990T3 (da) 2006-12-11

Similar Documents

Publication Publication Date Title
ZA981609B (en) Method of treating a tumor
AU747599C (en) Antitumor agents
HU9602937D0 (en) Compositions comprising dna damaging agents and p53
CY2473B1 (en) New phenanthridines.
PT880350E (pt) Tratamento de esclerose multipla
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
PL329802A1 (en) Derivatives of androstene
CA2388939A1 (fr) Traitements therapeutiques pour des deficiences en cellules sanguines
PL340679A1 (en) Application of a mixture of diole and alpha-hydroxyacid in treating
CA2408541A1 (fr) Traitement contre l'eczema et/ou le psoriasis
WO1998030585A3 (fr) Utilisation de pea3 en tant que suppresseur de tumeurs
ID24184A (id) Obat untuk perawatan disfungsi ereksi
AP1896A (en) The method of treating cancer
ATE243522T1 (de) Verwendung von tall-104 zellen in kombination mit adriamyzin oder cisplatin zur behandlung von malignen tumoren
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
EP1038524A4 (fr) L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
WO2000004153A3 (fr) Inhibition de la transformation cellulaire par la proteine pea3 humaine
DE69426986D1 (de) Behandlung von laminitis
RU94024337A (ru) Антиметастатическое средство
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
UA30460A (uk) Спосіб лікування системного аутоімунного захворювання
MX9602846A (es) Compuestos de vanadato para el tratamiento de desordenes proliferativos, metastasis, y tumores resistentes a los farmacos.